logo AIRI
News archive
Research and Development in Italy and in international value chains: R&D Airi statistical data Priority Technologies

Research and Development in Italy and in international value chains: R&D Airi statistical data

Research and Development in Italy in 2020

The effects of the pandemic on Research and Development were manifested in national R&D spending in 2020, with worse results than expected (ISTAT data).

This is 4.7% less than the previous year, with spending of just over 25 billion euros (at current prices).

Business spending (around 15.5 billion euros) suffers the greatest contraction (-6.8%) but a recovery is estimated as early as 2021 (+5.2% on 2020) and in 2022 (+3.9% on 2021).

The lockdown certainly affected the mobility of staff in company research centers (and in the laboratories of public institutions and universities) who continued to carry out mainly basic research while they had to contract applied research and development activities.

Businesses


The averages (-17% expense) and the small businesses (-27%) suffer the greatest contraction in investments in R&D while the larger and more structured companies have held the backlash on R&D carried out in house (+2.2%).

The extractive activities They are among the sectors that have suffered the worst performance in R&D spending, while the pharmaceutical, transport manufacturing, telecommunications services, healthcare and financial sectors have increased their activities.

The sources of financing


Even if reduced by 3%, the sources of financing (13.2 billion) of national R&D continue to come mainly from businesses (52.8%). Spending financed by the public (+1.4) and abroad (+1.7%) increases.
It is particularly interesting to note that in 2020 the sources of financing from foreign entities increased (around 2.8 billion) also in light of the dynamics of international value chains.

International R&D outsourcing


Excluding public ones and remaining among private foreign sources of financing, ISTAT data they say that in 2020 there were 432 Italian companies (with more than 50 employees) that provided R&D services abroad and 515 Italian companies that purchased R&D activities from abroad.

The share of R&D activities provided abroad in outsourcing by Italian companies is 10.1% and is exported by companies (432) belonging mainly to foreign multinational groups (42%) and Italian multinationals (40%).

As regards the companies that acquire R&D, this is a number that is divided into 372 companies active in Industry and 141 in Services. 45% of them are part of foreign multinational groups, 39% belong to Italian multinational groups.

R&D therefore remains one industrial component carried out mainly in Italy. This is also confirmed by the data on Research and Development activities entirely transferred abroad. In the period 2018-2020 they amounted to 7.6% of the total national activities delocalised, however the trend underlines a growth of the phenomenon compared to the previous three years.

In the period considered, the vast majority (64.4%) of national R&D activities were transferred within the EU27 or to other European countries (20%) and the UK (8.9%). Research and Development functions are also brought to the USA and Canada (13.3%) and more rarely to India (6.7%), China (4.4%), Central and South America (4.4%).

This low propensity to transfer has probably partly protected Italian R&D from collateral damage resulting from the effects of the repositioning of longer value chains, however the concentration of Italian R&D in the European Union probably exposes it more to the effects of new systemic crises of a geopolitical nature (economic war and energy crisis) which could have the worst consequences in the EU according to the OECD.

As regards the Research and Development of multinational companies in Italy, spending in 2020 stands at 4.1 billion, approximately a third of the R&D carried out by companies in Italy.

More than 2.5 billion of R&D is carried out by the manufacturing industry, with better performances than multinationals in the machinery manufacturing sector (512 million), in the manufacturing of computers and electrical equipment (511), chemical and pharmaceutical (446), automotive (415).

Most of these multinationals are controlled by companies resident in the United States (21.5% of R&D out of total foreign-controlled companies), France (17.5%), Germany (14.3%), and the United Kingdom (9.1%).

For further information: Download R&D Statistical data September 2022

For further information:

Investments in R&D and patents: the European Union in comparison with the United States and China - March 2022
International Research and Development. The inputs '20-'21 and the outputs '21-'22
Download R&S Statistical Data 2023